OnKure Therapeutics, Inc. OKUR Concurrent Financing Issuance Costs Included In Accounts Payable
Concurrent Financing Issuance Costs Included In Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept okur:ConcurrentFinancingIssuanceCostsIncludedInAccountsPayable.
The official record: OnKure Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s concurrent financing issuance costs included in accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s concurrent financing issuance costs included in accounts payable?
- OnKure Therapeutics, Inc. (OKUR) reported concurrent financing issuance costs included in accounts payable of $9.25K in Q4 2024.
- What does concurrent financing issuance costs included in accounts payable mean?
- Accrued costs associated with capital raising efforts that occurred simultaneously with other corporate transactions, recorded as accounts payable. This metric highlights outstanding obligations related to financing activities that will impact future cash flows.